THE CELL COMPANY Trademark

Trademark Overview

On Wednesday, November 22, 2023, a trademark application was filed for THE CELL COMPANY with the United States Patent and Trademark Office. The USPTO has given the THE CELL COMPANY trademark a serial number of 98282664. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 26, 2024. This trademark is owned by SCIENCE AI CORPORATION. The THE CELL COMPANY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Amino acids for medical purposes; Biological preparations for the treatment of general health and chronic diseases; Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Culture media for use in production of biopharmaceuticals, Vaccines, Cell-Based Therapies, Disease Models, Recombinant Proteins, Enzymes, Chemicals, Tissue, Organ Transplants, Gene Therapy, Monoclonal Antibodies, Cultivated Proteins; Enzyme preparations for medical purposes; Glucose for medical purposes

Biological research; Biotechnology research; DNA screening for scientific research purposes; Medical research services; Pharmaceutical research services; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific laboratory services; Scientific research; Scientific research consulting; Technical consulting in the field of pharmaceutical studies
the cell company

General Information

Serial Number98282664
Word MarkTHE CELL COMPANY
Filing DateWednesday, November 22, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, July 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAmino acids for medical purposes; Biological preparations for the treatment of general health and chronic diseases; Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Culture media for use in production of biopharmaceuticals, Vaccines, Cell-Based Therapies, Disease Models, Recombinant Proteins, Enzymes, Chemicals, Tissue, Organ Transplants, Gene Therapy, Monoclonal Antibodies, Cultivated Proteins; Enzyme preparations for medical purposes; Glucose for medical purposes
NOT AVAILABLE"COMPANY"
Goods and ServicesBiological research; Biotechnology research; DNA screening for scientific research purposes; Medical research services; Pharmaceutical research services; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific laboratory services; Scientific research; Scientific research consulting; Technical consulting in the field of pharmaceutical studies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 22, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSCIENCE AI CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94114

Trademark Events

Event DateEvent Description
Wednesday, November 22, 2023NEW APPLICATION ENTERED
Monday, February 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Monday, April 8, 2024NON-FINAL ACTION WRITTEN
Monday, April 8, 2024NON-FINAL ACTION E-MAILED
Monday, April 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 26, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, July 26, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords

company cell research medical purposes scientific services media clinical pharmaceutical proteins